CEP Certification Services India

Home CEP Certification Services India
CEP Certification Services India - Zymax Pharma

Zymax Pharma offers specialist CEP certification services in India for active pharmaceutical ingredient manufacturers seeking access to European and ICH-aligned markets. As defined by the EDQM Certificate of Suitability (CEP) procedure , a CEP confirms that an API's quality is adequately controlled by the relevant European Pharmacopoeia monograph. Our regulatory consultants guide Indian API manufacturers through dossier preparation, EDQM submission, and certificate maintenance for new and renewal CEP applications.

From initial gap assessment and dossier compilation to EDQM query response and post-approval variations, Zymax Pharma supports Indian API manufacturers through every stage of obtaining and maintaining a Certificate of Suitability.

What is a Certificate of Suitability (CEP)?

A Certificate of Suitability, commonly known as a CEP, is a certificate issued by the European Directorate for the Quality of Medicines and HealthCare confirming that the quality of a specific active pharmaceutical ingredient is suitably controlled by the corresponding European Pharmacopoeia monograph, taking into account the manufacturing process used by that specific manufacturer. In simple terms, it tells regulators and customers that your API consistently meets pharmacopoeial standards using your specific production route.

Unlike an ASMF, which is assessed alongside a specific marketing authorisation application, a CEP is issued independently of any particular finished product application. Once granted, the certificate can be referenced by multiple finished product manufacturers across multiple marketing authorisation applications in any country that recognises the European Pharmacopoeia, without requiring a full quality dossier resubmission each time.

For Indian API manufacturers, a CEP is one of the most valuable regulatory assets available. It significantly simplifies the path to market for customers purchasing your API, strengthens your competitive position, and demonstrates a verified level of quality control that builds long-term commercial trust.

Our CEP Certification Services in India

Zymax Pharma provides end-to-end CEP application support, from initial feasibility assessment through to certificate maintenance.

  • Monograph Suitability Assessment Evaluation of your API and manufacturing process against the relevant European Pharmacopoeia monograph to confirm CEP eligibility and identify any gaps before dossier preparation begins.
  • CEP Dossier Compilation Preparation of the complete CEP application dossier covering manufacturing process description, control of materials, control of critical steps and intermediates, specifications, and stability data in line with EDQM requirements.
  • eCTD Formatting for EDQM Submission Structuring and formatting of the CEP dossier in proper eCTD format for electronic submission through the EDQM's certification portal, ensuring correct module structure and document granularity.
  • EDQM Query and Deficiency Response Preparation of scientifically sound, well-documented responses to questions and deficiency letters raised by EDQM assessors during the evaluation phase, helping you reach certification without unnecessary delays.
  • CEP Renewal and Revision Support Management of CEP renewal applications and revision submissions following changes to your manufacturing process, site, or specifications, ensuring continued validity of your certificate.
  • CEP vs ASMF Strategy Consulting Guidance on whether the CEP route or the ASMF route is more appropriate for your API, based on monograph availability, target markets, customer requirements, and long-term commercial strategy.

Why CEP Certification Matters for Indian API Manufacturers

India is a major global supplier of active pharmaceutical ingredients, and a growing number of Indian API manufacturers are pursuing CEP certification to strengthen their position in European and other regulated markets. A valid CEP is often a prerequisite that finished product manufacturers look for when selecting an API supplier, as it significantly reduces their own regulatory burden.

However, the CEP application process is technically demanding. EDQM assessors conduct a thorough scientific review of the manufacturing process, impurity profile, and control strategy, and incomplete or poorly justified dossiers frequently result in multiple rounds of questions that extend timelines significantly.

A well-prepared CEP dossier with a scientifically sound control strategy and complete impurity qualification data is far more likely to proceed through EDQM assessment without extended deficiency cycles, saving Indian API manufacturers months of additional review time.

Zymax Pharma helps Indian API manufacturers prepare CEP dossiers that anticipate EDQM's scientific expectations from the outset, reducing the likelihood of repeated queries and helping you reach certification on a predictable timeline.

Why Choose Zymax Pharma for CEP Certification Services

Indian API manufacturers choose Zymax Pharma for CEP work because of our focused, technically grounded regulatory approach:

  • Specialist understanding of European Pharmacopoeia monograph requirements and EDQM assessment expectations.
  • Experience preparing CEP dossiers across multiple API categories including synthetic and semi-synthetic substances.
  • Strong eCTD formatting capability for proper EDQM portal submission.
  • Based in Gujarat with close proximity to major Indian API manufacturing clusters.
  • Proven track record managing EDQM query cycles and reducing deficiency response timelines.
  • Clear, practical guidance on choosing between CEP and ASMF routes based on your specific situation.

Frequently Asked Questions

A CEP is issued directly by the EDQM confirming that an API meets European Pharmacopoeia monograph requirements, and can be referenced by multiple applicants without resubmission. An ASMF is submitted alongside a specific marketing authorisation application and is assessed by the relevant national or EU procedure for that particular application.
A CEP is not strictly mandatory — API manufacturers can also support marketing authorisation applications through an ASMF or by including full API data directly in the marketing authorisation dossier. However, a CEP is widely preferred by finished product manufacturers because it reduces their regulatory workload and is recognised across multiple markets.
Dossier preparation typically takes 2 to 4 months depending on the complexity of the synthesis route and available data. EDQM assessment timelines vary, but a straightforward application with minimal queries can be certified within approximately 12 to 18 months from submission, while applications requiring multiple deficiency response cycles may take longer.
No. Only APIs with an existing European Pharmacopoeia monograph are eligible for the CEP procedure. If no monograph exists for your substance, the ASMF route or full dossier submission within the marketing authorisation application would be the appropriate path instead.
Any significant change to the manufacturing process, site, starting materials, or specifications after CEP approval requires a revision submission to the EDQM. Zymax Pharma helps assess whether a change qualifies as a minor or major revision and prepares the appropriate submission to maintain certificate validity.
Yes. While the CEP is issued under the European Pharmacopoeia framework, many countries outside Europe that recognise the European Pharmacopoeia also accept a valid CEP as supporting evidence of API quality, making it a valuable asset for global market access beyond the EU.
We focus exclusively on pharmaceutical regulatory affairs with specific technical experience in European Pharmacopoeia compliance and EDQM assessment expectations. Based in Gujarat, we work closely with Indian API manufacturers to prepare scientifically sound dossiers that minimise deficiency cycles and reach certification efficiently.

Need Support with Your CEP Application?

Speak with our CEP regulatory experts in India. Free initial consultation for new enquiries.

Get in Touch Today